» Articles » PMID: 18759354

Tiagabine for Essential Tremor: an Open-label Trial

Overview
Journal Mov Disord
Date 2008 Sep 2
PMID 18759354
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Antiseizure Drugs and Movement Disorders.

Saenz-Farret M, Tijssen M, Eliashiv D, Fisher R, Sethi K, Fasano A CNS Drugs. 2022; 36(8):859-876.

PMID: 35861924 DOI: 10.1007/s40263-022-00937-x.


Current and Future Neuropharmacological Options for the Treatment of Essential Tremor.

Alonso-Navarro H, Garcia-Martin E, Agundez J, Jimenez-Jimenez F Curr Neuropharmacol. 2020; 18(6):518-537.

PMID: 31976837 PMC: 7457404. DOI: 10.2174/1570159X18666200124145743.


Essential Tremor: What We Can Learn from Current Pharmacotherapy.

Ondo W Tremor Other Hyperkinet Mov (N Y). 2016; 6:356.

PMID: 26989572 PMC: 4790207. DOI: 10.7916/D8K35TC3.


Linking Essential Tremor to the Cerebellum-Animal Model Evidence.

Handforth A Cerebellum. 2015; 15(3):285-98.

PMID: 26660708 DOI: 10.1007/s12311-015-0750-0.


Linking Essential Tremor to the Cerebellum: Neurochemical Evidence.

Marin-Lahoz J, Gironell A Cerebellum. 2015; 15(3):243-52.

PMID: 26498765 DOI: 10.1007/s12311-015-0735-z.